CSIMarket
 


Humanigen Inc  (HGEN)
Other Ticker:  
 

Humanigen Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Humanigen Inc in the first quarter 2023?
Due to the lack of equity, it was not possible to calculate Humanigen Inc's return on equity (ROE) in its first quarter 2023

What is ROE?



Return On Equity (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -54 -71 -109 -152 -192
Return On Equity (TTM) - - - - -
HGEN's Total Ranking # # # # #
Equity (TTM) in Millions -50 -47 -52 -50 -25
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





HGEN Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions -47 -24 46 -14 -8
Y / Y Equity Change - - - - -
Net Income in Millions -71 -237 -90 -10 -12
Y / Y Net Income Change - - - - -
Return On Equity - - -196.59 % - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HGEN's' Return on Equity at Yahoo Finance
HGEN's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for HGEN's Competitors
Return On Equity for Humanigen Inc's Suppliers
Roe for HGEN's Customers




Companies with similar Return On Equity at Mar 31 2023, within Healthcare Sector ROE
Glucotrack Inc   272.80 %
Amgen Inc   209.99 %
Talphera Inc   178.53 %
Ir med Inc   177.83 %
Biovie Inc   155.65 %
Tenax Therapeutics Inc   146.87 %
Idexx Laboratories Inc  117.37 %
Halozyme Therapeutics Inc   116.10 %
Biomx Inc   109.90 %
Voyager Therapeutics Inc   95.18 %
Aptevo Therapeutics Inc   92.44 %
Davita Inc   88.54 %
Chimerix Inc   87.89 %
Chemomab Therapeutics Ltd   77.93 %
Medpace Holdings Inc   75.20 %
Vaso Corporation  69.41 %
Dariohealth Corp   68.87 %
Revelation Biosciences Inc   67.96 %
Ocuphire Pharma Inc   65.61 %
Kiniksa Pharmaceuticals ltd   59.32 %
Eli Lilly And Company  55.62 %
Shockwave Medical Inc   55.22 %
Science 37 Holdings Inc   52.82 %
Harmony Biosciences Holdings inc   52.77 %
Assertio Holdings inc   52.50 %
Zymeworks Inc   50.45 %
Abbvie inc   49.54 %
Arcturus Therapeutics Holdings Inc   48.59 %
Zoetis Inc   45.61 %
Dynavax Technologies Corporation  45.58 %


Date modified: 2023-05-17T02:14:02+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com